Ionara Bio

Stealth Mode Startup

Active Seed Startup Ness Ziona Founded 2024-05

Ionara Bio is developing novel, proprietary small molecules that target and block the TRPV2 channel—a key driver of inflammatory responses, particularly those involving macrophages, that impair cardiac structure and function following acute myocardial infarction (AMI). The company’s lead candidate, a first-in-class TRPV2 inhibitor, is designed to improve ca…